Feasibility of building a biotech industry
preprint
OA: closed
Abstract
The performance of the Cuban biotechnology from 2008 to 2021 has shown a growing pipeline of valuable biomedical solutions. As transformation of this sector into an industrial group has changed its R&D productivity and biomanufacturing capacity, we summarize here results of R&D projects with impact on public health, constraints found in Cuba, lessons, and opportunities to develop this science-based industry in developing countries.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-07-09T06:39:34.564547+00:00